STOCK TITAN

Advansix SEC Filings

ASIX NYSE

Welcome to our dedicated page for Advansix SEC filings (Ticker: ASIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Navigating Advansix’s labyrinth of disclosures—spanning raw-material hedging, air-emission permits, and nylon capacity utilisation—can feel overwhelming. Environmental liabilities, commodity price swings, and multi-site production data often hide deep inside a 300-page 10-K. Investors seeking a clear picture of how caprolactam spreads affect margins or how regulatory changes hit plant nutrients need more than a PDF download.

This page assembles every filing—10-K annual reports, 10-Q quarterly earnings, 8-K material events, Section 16 Form 4 insider transactions, and proxy statements—in real time, straight from EDGAR. Want the Advansix insider trading Form 4 transactions? They’re timestamped and searchable. Looking for the latest Advansix quarterly earnings report 10-Q filing or an Advansix proxy statement executive compensation breakdown? One click reveals AI-generated summaries, key tables, and red-flag alerts, so you can focus on decisions, not decoding accounting notes.

Stock Titan’s AI reads every footnote, surfaces segment sales for nylon, chemical intermediates, and plant nutrients, and highlights forward-looking risk language. Receive email or Slack alerts for Advansix Form 4 insider transactions real-time, compare year-over-year cash-flow trends, or track plant outage disclosures via Advansix 8-K material events explained. Whether you’re assessing dividend safety, benchmarking fertilizer exposure, or spotting Advansix annual report 10-K simplified KPIs, our platform transforms dense filings into clear, actionable insight—no Excel gymnastics required. It’s Advansix SEC filings explained simply, backed by AI you can trust.

Rhea-AI Summary

Enliven Therapeutics, Inc. (ELVN) – Form 4 insider transaction. Chief Financial Officer Benjamin Hohl exercised 3,250 employee stock options at an exercise price of $2.48 per share and immediately sold the same 3,250 shares under a pre-arranged Rule 10b5-1 trading plan dated 26 Jun 2023.

  • Option exercise: 3,250 shares converted from options granted 2 Aug 2021 (portion of a 262,120-share grant that vests monthly through Aug 2025).
  • Sales: 3,052 shares sold at a volume-weighted average price (VWAP) of $20.8609 and 198 shares at a VWAP of $21.6583; individual trade ranges were $20.58-$21.575 and $21.5811-$21.788, respectively.
  • Holdings after transactions: 23,000 shares of common stock held directly and 115,806 options outstanding.
  • The exercise-and-sell was executed the same day (27 Jun 2025) and disclosed 1 Jul 2025.

The transaction represents routine liquidity management by the CFO; the net economic exposure (shares plus remaining options) remains substantial.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 filing – NewMarket Corporation (NEU)

On July 1, 2025, non-employee director Mark M. Gambill received an annual equity grant of 144 shares of NewMarket common stock under the company’s 2023 Incentive Compensation and Stock Plan. The transaction is coded “A” (acquisition) and carries a stated price of $0, indicating a routine, company-awarded stock grant rather than an open-market purchase.

Following this grant, Gambill’s direct beneficial ownership increased to 3,992 shares. The filing reports no derivative security activity and no dispositions. The director remains classified as an insider (director) for Section 16 purposes, and the form was filed individually, not jointly.

Because the grant size is modest relative to NewMarket’s average daily trading volume and market capitalization, the transaction is considered routine and immaterial to the company’s overall float and insider ownership profile. No implications for earnings, guidance, or strategic direction are disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) – Form 4 insider filing

Director Patrick Williams reported the award of 5,020 restricted stock units (RSUs) on 18 June 2025 under the company’s 2016 Stock Incentive Plan. The RSUs were granted at $0 cost and will vest in full on 18 June 2026. Following the grant, Williams’ direct beneficial ownership rose to 33,641 common shares, which includes 76 dividend-equivalent shares credited on unvested awards. No open-market purchases, sales, or derivative security transactions were reported in the filing.

The disclosure reflects routine director equity compensation intended to align incentives with shareholders and does not represent a material change to the company’s capital structure or insider buying/selling trends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 4 overview

On 18 June 2025, AdvanSix Inc. (ASIX) reported that director Sharon S. Spurlin received 5,020 restricted stock units (RSUs) under the company’s 2016 Stock Incentive Plan. Coded “A” for acquisition, the award was issued at no cash cost and is scheduled to vest in full on 18 June 2026.

After the grant, Spurlin’s direct beneficial ownership rose to 74,746 common shares. The total includes 242 dividend-equivalent shares credited on prior unvested RSUs and deferred stock units, which were exempt from reporting under Rule 16a-11.

No derivative securities, open-market purchases, or sales were reported, making this a routine equity-compensation transaction rather than a signal of trading intent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) filed a Form 4 on 20 June 2025 disclosing that director Daniel F. Sansone received 5,020 restricted stock units (RSUs) on 18 June 2025 under the company’s 2016 Stock Incentive Plan. The grant, recorded at $0 purchase price, will vest in full on 18 June 2026. Following this transaction, Sansone’s total beneficial ownership stands at 36,288 common shares, which includes 106 dividend-equivalent shares accumulated on previously granted units. No derivative securities were reported, and the filing indicates the transaction was not executed under a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) filed a Form 4 disclosing a routine equity-compensation transaction. On 18-Jun-2025, director Donald P. Newman received 5,020 shares of common stock via a restricted stock unit (RSU) grant under the company’s 2016 Stock Incentive Plan. The transaction code was “A” (acquisition) and carried a stated price of $0 because no cash changed hands. All units will vest in full on 18-Jun-2026.

After the award, Mr. Newman’s direct beneficial ownership rose to 11,049 shares, which figure includes six dividend-equivalent shares automatically credited on previously unvested awards. No derivative securities were reported and no shares were sold.

This filing reflects normal director compensation designed to align governance interests with shareholders. The size of the award appears modest relative to AdvanSix’s market capitalization and does not, by itself, signal any shift in the company’s fundamentals or outlook.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 4 overview: On 18 June 2025 AdvanSix Inc. (ticker: ASIX) filed a Form 4 disclosing that director Gena C. Lovett received an equity award under the company’s 2016 Stock Incentive Plan.

The filing reports an automatic grant of 5,020 restricted stock units (RSUs) in AdvanSix common stock, recorded at a price of $0 because it is a compensation award rather than an open-market transaction. Per the footnotes, the RSUs will vest in full on 18 June 2026.

After the transaction, Lovett’s direct beneficial ownership stands at 15,162 shares. This total includes 60 dividend-equivalent stock units credited on previously granted RSUs and deferred stock units, which were exempt from reporting under Rule 16a-11.

The event is coded “A” (acquisition) and involves no sales, options, or other derivative securities. The filing does not reference a Rule 10b5-1 trading plan. Because the award represents routine director compensation and the share count is immaterial relative to AdvanSix’s outstanding shares, the disclosure is largely administrative and is unlikely to move the stock or alter the company’s capital structure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 Overview: On 06/18/2025, AdvanSix Inc. (ASIX) director Todd D. Karran was granted 5,020 restricted stock units (RSUs) under the company’s 2016 Stock Incentive Plan. The RSUs were awarded at $0 cost and will vest in full on 06/18/2026.

Post-transaction ownership: Following the grant, Karran’s direct beneficial ownership increased to 85,739 common shares. This figure already includes 491 dividend-equivalent shares accrued on previously awarded but unvested RSUs and deferred stock units, which were exempt from reporting under Rule 16a-11.

Key details:

  • Transaction code: “A” (award of securities)
  • Role: Director (not an officer)
  • Ownership form: Direct (D)
  • Rule 10b5-1 plan: No indication that the grant was made under a 10b5-1 trading plan.

Investor takeaway: The filing represents a routine equity incentive grant designed to further align the director’s interests with shareholders. No cash was exchanged, and there were no open-market purchases or sales. The lack of derivative transactions or dispositions suggests a neutral liquidity impact on the company’s float.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) filed a Form S-8 on 20 June 2025 to register 1,400,000 additional shares of common stock for issuance under its 2016 Stock Incentive Plan, as amended and restated on 18 June 2025. The new filing relies on General Instruction E, incorporating by reference three prior Form S-8 registrations that together covered 8,017,209 shares. Including the newly registered amount, the plan now provides for up to 9,417,209 shares of common stock.

The registration statement incorporates the company’s latest periodic reports: the 2024 Form 10-K, the Q1 2025 Form 10-Q, and five recent Form 8-Ks, thereby ensuring investors have current financial and operational information. The filing lists customary exhibits, including PricewaterhouseCoopers LLP’s consent and a legal opinion from General Counsel Achilles B. Kintiroglou, who beneficially owns 2,088 shares and options on 55,607 shares and is eligible to participate in the plan.

Standard Delaware exculpation and indemnification provisions for directors and officers are restated, and the document is executed by CEO Erin N. Kane and other senior officers and directors. No financial statements or earnings figures are presented; the filing’s sole purpose is to facilitate share issuance for employee and director equity compensation in accordance with the amended plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Advansix (ASIX)?

The current stock price of Advansix (ASIX) is $24.8 as of July 1, 2025.

What is the market cap of Advansix (ASIX)?

The market cap of Advansix (ASIX) is approximately 639.2M.

What are the core business areas of Advansix?

Advansix primarily operates in the production of nylon, chemical intermediates, and plant nutrients. The company also supplies critical products for various industrial and agrochemical applications.

How does Advansix maintain its operational efficiency?

Advansix maintains operational efficiency through its large-scale, state-of-the-art production facilities and a strong emphasis on research and development. Its integrated approach to manufacturing and robust logistics network further enhance its efficiency.

Where does Advansix primarily operate its manufacturing facilities?

The company is headquartered in New Jersey and operates major plants in locations including Chesterfield, VA, Hopewell, VA, Philadelphia, and Pottsville, PA. These facilities are among the most advanced in their category.

What role does research and development play at Advansix?

R&D is pivotal at Advansix, driving innovations in process technologies and new product development. The company’s R&D centers in North America, Asia, and India reinforce its competitive position in the diversified chemistry market.

How does Advansix differentiate itself from competitors?

Advansix differentiates itself through its fully integrated manufacturing operations, diversified product portfolio, and strong commitment to R&D. This enables the company to deliver reliable and innovative solutions across multiple industries.

What are the key markets served by Advansix?

Advansix serves a wide range of markets including industrial filament production, textiles, engineering plastics, packaging, and high-value agrochemical applications. Its diversified approach ensures broad market reach and a resilient supply chain.

How does Advansix manage its global supply chain?

The company leverages strategically located manufacturing plants and a robust logistics network to ensure reliable product distribution worldwide. Its integrated operations allow for quick response to local and global market demands.

What type of products are included in Advansix's portfolio?

Advansix’s portfolio encompasses key products such as nylon, caprolactam, plant nutrients, and various chemical intermediates. These products are essential in numerous applications ranging from industrial manufacturing to high-value crop production.
Advansix

NYSE:ASIX

ASIX Rankings

ASIX Stock Data

639.21M
25.90M
3.51%
92.31%
1.22%
Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
PARSIPPANY